Special Article| Volume 21, ISSUE 9, P1191-1196, September 2020

Challenges in Tracking and Reporting Antibiotic Use in Long-Term Care

  • H. Edward Davidson
    Address correspondence to H. Edward Davidson, PharmD, MPH, Insight Therapeutics, 150 Boush Street, Suite 1005, Norfolk, VA 23510.
    Insight Therapeutics, Norfolk, VA

    Clinical Internal Medicine, Eastern Virginia Medical School, Norfolk, VA
    Search for articles by this author
  • Robin L.P. Jump
    Geriatric Research Education and Clinical Center (GRECC), VA Northeast Ohio Healthcare System, Cleveland, OH

    Division of Infectious Diseases and HIV Medicine, Department of Medicine and Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, OH
    Search for articles by this author


      The contemporary long-term care provider and interdisciplinary team are well aware of the recent focus on antibiotic use in their settings. Regulatory changes implemented by Centers for Medicare and Medicaid Services beginning in 2016 have required long-term care settings to look at antibiotic use in a more comprehensive way and to align their programs with the Centers for Disease Control and Prevention's Core Elements for Antibiotic Stewardship for Nursing Homes. As long-term care settings have worked to develop antibiotic stewardship programs over the past several years, there have been many discoveries about the processes involved in gathering data about antibiotic use and associated attributes, including dose, duration of therapy, and indication for use. Attempts to align these attributes with appropriateness may require integration of data elements from pharmacy records and the individual resident's electronic medical record. In this article, we systematically discuss relevant antibiotic use metrics, sources of antibiotic use data, collecting and reporting antibiotic use data, concluding with implications for policy, practice, and research. Only by measuring antibiotic use can we start to assess the effectiveness of antibiotic stewardship program to induce meaningful change in the care of residents in long-term care.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. MDS 3.0 Frequency Report | CMS.
        (Available at:)
      2. Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities. Federal Register.
        (Available at:)
      3. The Core Elements of Antibiotic Stewardship for Nursing Homes | Nursing Homes and Assisted Living (LTC) | CDC.
        (Available at:)
        • Jump R.L.P.
        • Gaur S.
        • Katz M.J.
        • et al.
        Template for an antibiotic stewardship policy for post-acute and long-term care settings.
        J Am Med Dir Assoc. 2017; 18: 913-920
        • Dellit T.H.
        • Owens R.C.
        • McGowan J.E.
        • et al.
        Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.
        Clin Infect Dis. 2007; 44: 159-177
      4. Toolkit 2: Monitor and Sustain Stewardship.
        (Available at:)
      5. For Nursing Homes | Rochester Patient Safety Collaborative.
        (Available at:)
      6. WHOCC - Definition and general considerations.
        (Available at:)
        • Hutchinson J.M.
        • Patrick D.M.
        • Marra F.
        • et al.
        Measurement of antibiotic consumption: A practical guide to the use of the anatomical therapeutic chemical classification and defined daily dose system methodology in Canada.
        Can J Infect Dis. 2004; 15: 29-35
        • Polk R.E.
        • Fox C.
        • Mahoney A.
        • et al.
        Measurement of adult antibacterial drug use in 130 US hospitals: Comparison of defined daily dose and days of therapy.
        Clin Infect Dis. 2007; 44: 664-670
        • Crnich C.J.
        • Jump R.
        • Trautner B.
        • et al.
        Optimizing antibiotic stewardship in nursing homes: A narrative review and recommendations for improvement.
        Drugs Aging. 2015; 32: 699-716
        • Kalil A.C.
        • Metersky M.L.
        • Klompas M.
        • et al.
        Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
        Clin Infect Dis. 2016; 63: e61-e111
        • Metlay J.P.
        • Waterer G.W.
        • Long A.C.
        • et al.
        Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America.
        Am J Respir Crit Care Med. 2019; 200: e45-e67
        • Ashraf M.S.
        • Gaur S.
        • Bushen O.Y.
        • et al.
        Diagnosis, treatment, and prevention of urinary tract infections in post-acute and long-term care settings: A consensus statement from AMDA's Infection Advisory Subcommittee.
        J Am Med Dir Assoc. 2020; 21: 12-24.e2
        • Stevens D.L.
        • Bisno A.L.
        • Chambers H.F.
        • et al.
        Practice guidelines for the diagnosis and management of skin and soft-tissue infections.
        Clin Infect Dis. 2005; 41: 1373-1406
        • Kabbani S.
        • Palms D.L.
        • Bartoces M.
        • et al.
        Potential utility of pharmacy data to measure antibiotic use in nursing homes.
        Infect Control Hosp Epidemiol. 2019; 40: 819-820
        • Felsen C.B.
        • Barney G.R.
        • Dumyati G.K.
        Innovative methods to summarize nursing home antibiotic data.
        Infect Control Hosp Epidemiol. 2019; 40: 1210-1211
        • Bjarnadottir R.I.
        • Herzig C.T.A.
        • Travers J.L.
        • et al.
        Implementation of electronic health records in U.S. nursing homes.
        Comput Inform Nurs. 2017; 35: 417-424
      7. QAPI Resources | CMS.
        (Available at:)
        • Fanikos J.
        • Jenkins K.L.
        • Piazza G.
        • et al.
        Medication use evaluation: Pharmacist rubric for performance improvement.
        Pharmacother. 2014; 34: 5S-13S
        • Blaszczyk A.T.
        • Anderson S.S.
        • Hall R.G.
        Appropriateness of fluoroquinolone prescribing in the long-term care setting.
        J Am Geriatr Soc. 2020; 68: 661-663
      8. Medicare State Operations Manual, Appendix PP: Interpretive Guidelines for Long-Term Care Facilities.
        (Available at:)
      9. Long-term Care Facilities | NHSN | CDC.
        (Available at:)
        Date accessed: July 17, 2016

      Related Podcast

      September 29, 2020

      September 2020 Issue

      Featuring Dr. Philip Sloane, Dr. Mallory Brown; Recorded: September 16, 2020.

      Loading ...